HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Wu Selected Research

aerobactin

1/2017Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils.
10/2015[The clinical and bacterial features of Klebsiella pnuemoniae liver abscess].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Wu Research Topics

Disease

83Neoplasms (Cancer)
10/2022 - 04/2004
29Infections
08/2022 - 10/2007
29Neoplasm Metastasis (Metastasis)
01/2022 - 07/2005
17Inflammation (Inflammations)
01/2022 - 10/2014
14Hepatocellular Carcinoma (Hepatoma)
10/2020 - 05/2007
11Breast Neoplasms (Breast Cancer)
09/2022 - 06/2004
11Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 11/2014
10Carcinogenesis
02/2022 - 11/2014
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 08/2005
8Lung Neoplasms (Lung Cancer)
01/2022 - 10/2012
7Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 04/2009
7Nasopharyngeal Carcinoma
01/2022 - 07/2005
7Liver Neoplasms (Liver Cancer)
01/2021 - 01/2006
6Carcinoma (Carcinomatosis)
04/2018 - 01/2004
6Diarrhea
01/2017 - 04/2014
5COVID-19
05/2022 - 01/2020
5Osteosarcoma (Osteogenic Sarcoma)
06/2021 - 05/2011
5Hypoxia (Hypoxemia)
04/2019 - 11/2014
5Rheumatoid Arthritis
02/2016 - 12/2010
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 09/2011
4Adenocarcinoma of Lung
01/2020 - 12/2012
3Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 10/2014
3Lymphatic Metastasis
01/2022 - 02/2019
3Lung Injury
01/2022 - 02/2019
3Vesicular Stomatitis
01/2022 - 10/2007
3Asthma (Bronchial Asthma)
01/2021 - 09/2005
3Fibrosis (Cirrhosis)
01/2021 - 01/2016
3Peritoneal Neoplasms
01/2021 - 12/2007
3Human Influenza (Influenza)
10/2020 - 06/2011
3Adenocarcinoma
01/2020 - 09/2014
3Osteoporosis
12/2019 - 10/2014
3Squamous Cell Carcinoma of Head and Neck
02/2019 - 01/2014
3Sepsis (Septicemia)
01/2019 - 01/2016
3Porcine Reproductive and Respiratory Syndrome (PRRS)
04/2018 - 05/2012
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 01/2016
3Anemia
01/2015 - 10/2004
3Glioma (Gliomas)
12/2014 - 05/2013
3Thrombosis (Thrombus)
06/2010 - 02/2008
2Thyroid Neoplasms (Thyroid Cancer)
10/2022 - 01/2022
2Melanoma (Melanoma, Malignant)
09/2022 - 01/2022
2Diabetic Foot
08/2022 - 09/2017
2Ulcer
08/2022 - 09/2017
2Colitis
01/2022 - 02/2016
2Ischemia
01/2022 - 01/2006

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2004
18Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 10/2007
15Biological ProductsIBA
12/2021 - 05/2007
11Peptides (Polypeptides)IBA
09/2022 - 06/2008
9Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2018
91,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 - 11/2014
8CytokinesIBA
01/2022 - 08/2011
8IntegrinsIBA
01/2022 - 07/2013
7VaccinesIBA
01/2022 - 05/2012
71,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2020 - 11/2014
6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2017
6Pharmaceutical PreparationsIBA
10/2020 - 04/2004
6Neutralizing AntibodiesIBA
10/2020 - 02/2011
6Small Interfering RNA (siRNA)IBA
01/2020 - 12/2012
6ErbB Receptors (EGF Receptor)IBA
01/2017 - 12/2007
5AntibodiesIBA
09/2022 - 01/2016
5TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2022 - 01/2016
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2006
5Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2017 - 03/2010
4RNA (Ribonucleic Acid)IBA
09/2021 - 04/2018
4Monoclonal AntibodiesIBA
07/2021 - 01/2006
4Messenger RNA (mRNA)IBA
03/2021 - 03/2015
4Tyrosine Kinase InhibitorsIBA
02/2021 - 07/2015
4Therapeutic UsesIBA
01/2021 - 01/2006
4Immunoglobulin G (IgG)IBA
01/2020 - 01/2013
4Cadherins (E-Cadherin)IBA
10/2016 - 11/2014
3Radioisotopes (Radionuclides)IBA
10/2022 - 01/2019
3AntigensIBA
09/2022 - 09/2014
368Ga-FAPIIBA
01/2022 - 01/2021
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2004
3Estrogen ReceptorsIBA
01/2022 - 01/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 07/2015
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 11/2014
32,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
11/2021 - 04/2017
3ImipenemFDA Link
01/2021 - 11/2019
3Immunoglobulin E (IgE)IBA
01/2021 - 01/2012
3Evans Blue (Blue, Evans)FDA Link
01/2020 - 01/2006
3CateninsIBA
01/2019 - 01/2011
3Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2014 - 08/2002
2Circular RNAIBA
02/2022 - 10/2020
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2022 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2019
2Dextrans (Dextran)FDA Link
01/2022 - 01/2019
2FluorineIBA
01/2022 - 01/2021
2ORALIT (ORS)IBA
01/2022 - 09/2017
2Neuropilin-1IBA
01/2022 - 12/2014
2AntioxidantsIBA
01/2022 - 09/2016
2Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022 - 08/2009

Therapy/Procedure

50Therapeutics
10/2022 - 06/2008
15Radiotherapy
10/2021 - 08/2005
7Drug Therapy (Chemotherapy)
01/2021 - 07/2005
5Chemoradiotherapy
12/2020 - 01/2014
4Length of Stay
08/2021 - 04/2012
3Immunotherapy
09/2022 - 01/2019
3Aftercare (After-Treatment)
01/2017 - 10/2009
2Operative Surgical Procedures
01/2022 - 04/2012